Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-12

FDA Approved: VIGABATRIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA granted supplemental approval for Vigabatrin from Amneal Pharmaceuticals NY LLC under ANDA210042, enabling a revised/expanded approval for the generic produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)